Gut bacteria clues could unlock liver disease mysteries

NCT ID NCT07455175

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how changes in gut bacteria, driven by a substance called lactate, might be linked to the worsening of liver cirrhosis. Researchers will follow 200 people, including healthy volunteers and cirrhosis patients, to measure lactate levels in blood, stool, and tissue. The goal is to better understand the disease and find new ways to track its progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help identify new ways to track or slow liver cirrhosis progression by targeting gut bacteria.

What could go wrong

This is an early observational study, not a treatment trial. It may find no clear link, and results may not lead to direct patient benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong, 510000, China